The collaboration offers to customers in need of high volume commercial production... Oct 30
Teplizumab, Provention Bio’s lead drug candidate, is an anti-CD3 monoclonal antibody (mAb) being developed for the delay or prevention of type 1 diabetes ... Aug 29
Saiba AG and AGC Biologics come together for developing Coronavirus vaccine... Jun 17
-Advertisements-